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Abstract. Pleomorphic adenoma is the most common salivary gland neoplasm and
infrequently undergoes malignant transformation. Carcinoma ex pleomorphic
adenoma is typically an infiltrative neoplasm with features of cellular
pleomorphism, high mitotic activity, peri-neural and vascular invasion. More
recently, sub-groups of pleomorphic adenoma have been described exhibiting
vascular invasion and features of malignancy without evidence of extra-capsular
extension. There is little information in the literature regarding how these different
histological variants influence clinical presentation and outcome following primary
treatment.
Following a review of 100 consecutive pleomorphic adenomas removed from the
major salivary glands, 4 cases with atypical histological features were found. Three
tumours exhibited features of dysplasia/carcinoma without evidence of extra-
capsular invasion and a further case demonstrated benign vascular invasion. There
were no clinical features suggestive of the atypical nature of these neoplasms,
though fine needle aspiration cytology (FNAC) was suspicious of a malignancy in 2
cases and CT scan in 1 case. Patients underwent a superficial parotidectomy or
submandibular gland excision based on the location of the lesion. All lesions were
completely excised and there were no recurrences in this series.
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mon benign salivary gland tumour. It is
epithelially derived and typically presents
as a cytologically benign circumscribed
mass with variable encapsulation8,9,19,21.
Histomorphically it is characterized by a
variegated architecture comprising epithe-0901-5027/070608 + 05 $30.00/0 # 2006 Internalial elements admixed with a mucoid,
myxoid, fibrohyaline or chondroid stoma.
Historically, the main clinical problems
with pleomorphic adenoma have been the
risk of recurrence and progression to a
clinically- or histologically-based malig-
nancy19.tional Association of Oral and Maxillofacial SurgeoOver recent years there has emerged a
rare but nonetheless well-documented
subgroup of pleomorphic adenoma enti-
ties that require additional awareness and
precise recognition in terms of their pro-
pensity for future aggressiveness. These
include features of vascular invasion1,6,23,ns. Published by Elsevier Ltd. All rights reserved.
Atypical features in pleomorphic adenoma—a clinicopathologic study and implications for management 609
Table 1. Synopsis of patients with atypical pleomorphic adenoma
Case Age/sex Clinical features FNAC* Imaging Histology Treatment Follow-up
1 48/F 3 cm  2 cm mass,


















































4 77/M 2 cm  2 cm mass,
tail of parotid, present
5 months, normal
facial nerve function













* FNAC, fine needle aspiration cytology.
yPA, pleomorphic adenoma.
zANED, alive with no evidence of disease.focal dysplasia2,5 and non-invasive (intra-
capsular) carcinoma ex pleomorphic ade-
noma3,10,13,14. There is little information
in the literature regarding how these dif-
ferent histological variants influence clin-
ical presentation and outcome following
primary treatment.
This paper presents 4 cases outlining
these variants and examines the literature
regarding this sub-group of pleomorphic
adenoma, offering implications for man-
agement.Fig. 1. Island of tumour cells within a vessel outside of the tumour specimen. Normal parotid
tissue can be seen in the top right (original magnification 60, H&E).Patients and methods
The case records and histology reports of
100 consecutive cases of pleomorphic
adenoma of the major salivary glands
treated at the Queen Alexandra Hospital,
Portsmouth were reviewed and patients
with atypical features identified. Four
cases were noted to have atypical features
and form the basis of this study. The age
range was 47–77 years and included 3
female and 1 male patient. The lesion
affected the parotid gland in 3 cases and
the submandibular gland in 1 case. Two
cases of non-invasive (intra-capsular) car-
cinoma, 1 case of focal dysplasia and a
further case of benign vascular invasion
were identified. The demographic charac-
teristics, clinical presentation, results of
investigations undertaken and outcome of
these patients were analysed and are sum-
marized in Table 1.
The histological features of these cases
are described in the following sections.Case 1
Cellular pleomorphic adenoma was sur-
rounded by a fibrous capsule, with no
signs of atypia or malignancy. In addition,
the presence of benign-looking tumour
cells within vessels outside the main
tumour was also noted. These features
were interpreted as benign vascular inva-
sion (Figs 1 and 2).Case 2
Chondro-myxoid pleomporphic adenoma,
with no evidence of malignancy. Very
close to the periphery, however, there
was a small focus of atypical change
within the epithelial cells, in which the
cells were arranged in more solid cords
and showed enlarged, pale, pleomorphic
nuclei. The atypical cells had abundant
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Fig. 2. Tumour island within a vessel. The endothelial lining of the vessel highlighted with
CD34 (original magnification 60, immunohistochemistry CD34).eosinophilic cytoplasm and mitoses were
not seen (Fig. 3). These changes were best
regarded as ‘dysplasia within a pleo-
morphic adenoma’.Fig. 3. Chondromyxoid pleomorphic adenoma
morphic cells with abundant eosinophilic cytopl
consistent with dysplasia (original magnificationCase 3
Well circumscribed pleomorphic adenoma
surrounded by a fibrous capsule, which waswith an area displaying (inset, 100) pleo-
asm, hyperchromatic and pleomorphic nuclei
60, H&E).not infiltrated by tumour. In addition to the
presence of definite benign areas, there was
marked cellular atypia and malignant
changes occupying most of the tumour
mass. These changes were seen in the clear
cells, solid and papillary areas of the
tumour (Fig. 4). This tumour was reported
as a non-invasive (intra-capsular) carci-
noma in a pleomorphic adenoma.Case 4
Well circumscribed pleomorphic ade-
noma was surrounded by a fibrous capsule.
In addition there was a focal area of
carcinomatous change with cells exhibit-
ing eosinophilic cytoplasm, atypical
nuclei, prominent nucleoli and mitosis.
The appearances were considered to be
similar to that of a salivary duct carci-
noma. There was no evidence of vascular
or peri-neural invasion and the tumour was
confined by capsular tissues (Fig. 5). This
tumour was reported as a non-invasive
(intra-capsular) carcinoma in pleomorphic
adenoma.Discussion
Pleomorphic adenoma is the most com-
mon neoplasm of the salivary glands and
infrequently undergoes malignant trans-
formation8,9,19,21. The propensity for
malignant transformation (either clinical
or histological) has been documented in
the literature at 1.9–23.3% and carcinoma
ex pleomorphic adenoma represents
approximately 12% of malignant neo-
plasms8,9,12–15,17,20,24. The clinical diag-
nosis is based on local features of
malignancy in addition to regional or dis-
tant metastasis while the tissue diagnosis
is based on the identification of features of
invasion and cellular atypia. The 3 com-
mon sub-types of malignant change
described are carcinoma ex pleomorphic
adenoma, true malignant mixed tumour
(carcino-sarcoma) and metastasising
mixed tumour4,12–15,17–20,24,25.
The tendency to progress to malignancy
has traditionally been based on the diag-
nostic criteria for carcinoma ex pleo-
morphic adenoma (a mixed tumour in
which a second epithelial tumour devel-
ops). It typically is an infiltrative neoplasm
showing invasion of salivary parenchyma
with extension into adjacent structures,
high mitotic rate, nuclear pleomorphism,
peri-neural involvement, vascular inva-
sion and necrosis13,14. The prognosis of
carcinoma ex pleomorphic adenoma is
dependant on the size, grade, extent of
invasion and the presence of regional
and distant metastasis13,14,15,21,24.
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Fig. 4. Typical appearances of pleomorphic adenoma found in a small area of the tumour
specimen. Inset (lower left, 60) demonstrating large pleomorphic cells with hyperchromatic,
pleomorphic nuclei and prominent nucleoli. Inset (upper right, 100) demonstrating abnormal
mitosis in addition to the cellular and nuclear atypia (original magnification 40, H&E).The implications of benign vascular
invasion, focal dysplasia and non-invasive
(intra-capsular) carcinoma occurring in a
benign pleomorphic adenoma however,
still remain poorly understood.
The presence of vascular invasion in a
benign pleomorphic adenoma is uncom-
mon1,6,23. This has mostly been reported in
minor salivary gland tumours, and these
authors know of only one documented
report involving the parotid gland1. In thisFig. 5. A small focus of high grade carcinoma
adenoma (inset, 60), demonstrating comedo-n
(original magnification 40, H&E).series, the vascular invasion was present in
a tumour originating from the parotid
gland, and was considered to represent
true vascular invasion rather than tumour
embolus or artefactual spillage based on
criteria similar to that described by COLE-
MAN & ALTINI6. Though the presence of
vascular invasion has been associated
with a higher grade of malignancy and
metastatic potential in a wide variety of
malignant tumours, the implications of vas-within the tumour capsule in a pleomorphic
ecrosis, cytological atypia and apoptotic cellscular invasion in a benign pleomorphic
adenoma remains unknown. The relation-
ship between benign vascular invasion and
metastasising pleomorphic adenoma has
not been established and the presence of
vascular invasion has not been documented
in any of the reported cases of metastasising
pleomorphic adenoma4,18,25. It was, how-
ever, interesting to note that most instances
of metastasising pleomorphic adenoma
have been reported from the parotid gland,
whereas benign vascular invasion has been
more frequent in minor salivary glands.
There is currently little evidence to suggest
more aggressive treatment of these patients,
though it is likely that a more critical
follow-up regimen may be warranted to
define its significance.
Malignant change in a pleomorphic
adenoma has been associated with long
duration of the tumour, recurrent tumour,
radiotherapy, increasing age of patient and
tumour size12,14,20. It is interesting to note
that none of our patients had any previous
surgery or radiotherapy and the largest
tumour was 4 cm  3 cm. The lesions
were present for many years in 2 of the
3 patients who developed non-invasive
(intra-capsular) carcinoma ex pleo-
morphic adenoma. The progression from
dysplastic epithelium and/or adenoma
through to carcinoma is well recognized
in colorectal carcinogenesis and is related
to accumulation of genetic mutations.11 In
our series, there were cases of focal dys-
plasia, small focus of obvious malignant
change and malignant change involving a
significant portion of the gland, all without
evidence of capsular invasion. It is tempt-
ing to postulate a similar progression in
benign salivary gland pleomorphic ade-
noma to invasive carcinoma ex pleo-
morphic adenoma.
AUCLAIR & ELLIS2 found atypical cells in
2% of benign pleomorphic adenoma in the
Armed Forces Institute of Pathology files,
and their presence was associated with an
increased incidence of malignant change,
especially those with hyalinization, necro-
sis and high mitotic rate. More recently,
molecular and histogenetic studies have
suggested that a greater proportion of
benign pleomorphic adenoma exhibit
abnormal foci, though their precise sig-
nificance in relation to malignant change
remains uncertain7,16,22.
Though carcinoma ex pleomorphic ade-
noma accounts for approximately 12% of
malignant salivary gland tumours, we are
aware of only 15 previous cases of non-
invasive (intra-capsular) carcinoma ex
pleomorphic adenoma reported in the
English literature3,10,13,14. In 9 of these
cases the tumour arose in a major salivary
612 Ethunandan et al.gland and in the remaining 6 cases
reported, the site of the tumour was not
documented.
There is very little information in the
literature pertaining to the clinical presen-
tation and results of preoperative investi-
gations undertaken in this group of
patients. In this series all patients had a
noticeable mass in the salivary gland of
long duration (6 months–many years),
though none exhibited any salient clinical
features of malignancy. The imaging
investigation was suggestive of a malig-
nant lesion in 1 case and the fine needle
aspiration was inconclusive in 1 case,
suggestive of a pleomorphic adenoma in
1 case and in 2 patients there was a
suspicion of malignancy (Table 1).
Previous reports of non-invasive (intra-
capsular) carcinoma ex pleomorphic ade-
noma, seem to suggest an excellent prog-
nosis for these lesions, with no evidence of
recurrence or metastasis if these lesions
are completely excised3,13,14. They found
the absence of capsular invasion corre-
lated with a ‘benign’ clinical course of
these neoplasms. TORTOLEDO et al.24 had
previously demonstrated the prognostic
significance of neoplastic extension
beyond the capsular confines and sug-
gested that carcinoma ex pleomorphic
adenoma which extended less than
8 mm beyond the residual capsule was
associated with a good prognosis, regard-
less of the grade of the tumour.
FELIX et al.10, however, reported a case of
high grade intra-capsular carcinoma ex
pleomorphic adenoma, which initially pre-
sented as metastatic cervical lymphadeno-
pathy of unknown origin and was
subsequently found to originate from a deep
lobe of the parotid. The patient underwent a
total parotidectomy and cervical lympha-
denectomy and received adjuvant radio-
therapy and remained free of disease.
The natural history of these non-inva-
sive (intra-capsular) carcinoma ex pleo-
morphic adenoma, if left untreated, is
unknown. It would be reasonable to spec-
ulate that the excellent prognosis of these
lesions is associated with fact that they
were removed at an early stage in their
tumour progression, prior to the develop-
ment of capsular invasion and metastatic
potential. The authors of the present study
concur with previous reports that pleo-
morphic adenoma with focal areas of
malignant change should be carefully
assessed by serial sectioning to document
evidence of capsular invasion3,14. Theprognosis and future therapy will depend
on careful study of these lesions.References
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